Platinum completes $2.1 bln LifeScan buy
Platinum Equity said Oct. 2 its $2.1 billion buy of LifeScan from Johnson & Johnson has closed. LifeScan provides blood glucose monitoring products.
Platinum Equity said Oct. 2 its $2.1 billion buy of LifeScan from Johnson & Johnson has closed. LifeScan provides blood glucose monitoring products.